United Therapeutics Corporation (UTHR) — Cash Flow Reinvestment Rate
United Therapeutics Corporation (UTHR) has a Cash Flow Reinvestment Rate of 0.63x as of September 2025, reinvesting $351.40 Million (capex $210.50 Million plus investments $140.90 Million) from operating cash flow of $562.10 Million. Check how high is United Therapeutics Corporation's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
United Therapeutics Corporation Cash Flow Reinvestment Rate (2004–2024)
Historical reinvestment intensity for United Therapeutics Corporation across 19 annual periods. Explore United Therapeutics Corporation (UTHR) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for United Therapeutics Corporation (2004–2024)
Year-by-year capital reinvestment analysis for United Therapeutics Corporation. For live market cap and broader valuation context, see United Therapeutics Corporation stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | $663.70 Million | $1.33 Billion | $246.50 Million | ▼ -58.6% |
| 2023 | 1.21x | $1.18 Billion | $978.00 Million | $230.40 Million | ▲ +17.9% |
| 2022 | 1.02x | $822.40 Million | $802.50 Million | $138.80 Million | ▲ +25.9% |
| 2021 | 0.81x | $486.90 Million | $598.20 Million | $120.80 Million | ▼ -17.0% |
| 2020 | 0.98x | $740.90 Million | $755.70 Million | $59.30 Million | ▲ +17.3% |
| 2018 | 0.84x | $650.50 Million | $778.40 Million | $184.40 Million | ▼ -53.0% |
| 2017 | 1.78x | $844.00 Million | $474.20 Million | $86.30 Million | ▲ +750.4% |
| 2016 | 0.21x | $134.70 Million | $643.60 Million | $43.20 Million | ▼ -68.4% |
| 2015 | 0.66x | $253.16 Million | $382.80 Million | $49.79 Million | ▼ -45.8% |
| 2014 | 1.22x | $433.34 Million | $355.30 Million | $47.44 Million | ▲ +75.8% |
| 2013 | 0.69x | $294.97 Million | $425.27 Million | $31.91 Million | ▲ +37.4% |
| 2012 | 0.50x | $163.36 Million | $323.63 Million | $111.91 Million | ▲ +7.2% |
| 2011 | 0.47x | $117.78 Million | $250.19 Million | $35.98 Million | ▼ -55.4% |
| 2010 | 1.05x | $223.14 Million | $211.53 Million | $18.64 Million | ▲ +10.3% |
| 2009 | 0.96x | $95.40 Million | $99.72 Million | $95.40 Million | ▲ +21.1% |
| 2007 | 0.79x | $38.66 Million | $48.95 Million | $38.66 Million | ▲ +149.5% |
| 2006 | 0.32x | $15.63 Million | $49.39 Million | $15.63 Million | ▲ +123.4% |
| 2005 | 0.14x | $6.12 Million | $43.17 Million | $6.12 Million | ▼ -43.6% |
| 2004 | 0.25x | $5.22 Million | $20.78 Million | $5.22 Million | — |